Table 5.
Distribution of pathogens in different oncology populationsa
| Pathogens | Hematologic/HSCT N (%) | Solid tumor N (%) | Pediatricb N (%) | |||
|---|---|---|---|---|---|---|
| GPP | BFGP | GPP | BFGP | GPP | BFGP | |
| Any pathogen | 33 (37.9%) | 38 (43.6%) | 23 (27.7%) | 30 (36.1%) | 12 (60%) | 13 (65%) |
| Multiple pathogens | 3 (3.4%) | 8 (9.2%) | 1 (1.2%) | 9 (10.8%) | 2 (10%) | 5 (25%) |
| C. difficile | 18 | 20 | 12 | 16 | 7 | 7 |
| Shigella | 1 | 1 | 1 | 1 | 1 | 1 |
| E. coli O157:H7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Salmonella species | 4 | 4 | 1 | 1 | 0 | 0 |
| Campylobacter species | 4 | 3 | 2 | 2 | 1 | 2 |
| STEC | 1 | 1 | 1 | 1 | 1 | 0 |
| ETEC | 2 | 2 | 1 | 2 | 1 | 0 |
| EAEC | n/a | 1 | n/a | 4 | n/a | 1 |
| EIEC | n/a | 0 | n/a | 0 | n/a | 0 |
| EPEC | n/a | 8 | n/a | 8 | n/a | 4 |
| Plesiomonas shigelloides | n/a | 0 | n/a | 0 | n/a | 0 |
| Yersinia enterolitica | n/a | 0 | n/a | 0 | n/a | 0 |
| Vibrio cholerae /species | 0 | 0 | 0 | 0 | 0 | 0 |
| Norovirus GI/GII | 5 | 5 | 4 | 5 | 2 | 2 |
| Rotavirus A | 0 | 0 | 0 | 0 | 0 | 0 |
| Adenovirus | 1 | 0 | 0 | 0 | 0 | 0 |
| Astrovirus | n/a | 0 | n/a | 1 | n/a | 0 |
| Sapovirus | n/a | 0 | n/a | 0 | n/a | 0 |
| Cryptosporidium spp. | 1 | 1 | 0 | 0 | 1 | 1 |
| Giardia lamblia | 0 | 0 | 2 | 2 | 1 | 1 |
| Entamoeba histolytica | 1 | 0 | 0 | 0 | 0 | 0 |
| Cyclospora cayetanensis | n/a | 0 | n/a | 0 | n/a | 0 |
a
HSCT: Hematopoietic Stem Cell Transplant;
b
Pediatric patients (included in the total hematologic (n=11)/solid tumors numbers (n=5)). STEC: Shiga-toxin producing E. coli; ETEC: Enterotoxigenic E. coli; EAEC: Enteroaggregative E. coli; EIEC: Enteroinvasive E. coli; EPEC: Enteropathogenic E. coli. N/A: Not applicable (target not included on panel)